News

Tuberculosis tests like sputum, blood and CBNAAT help in early detection. Here's a simple guide to TB symptoms, diagnosis and ...
First-of-its-kind systematic review on the clinical relevance of test values from the QuantiFERON-TB Gold Plus TB1 and TB2 blood collection tubes has been published // Study including 4,050 ...
QuantiFERON is an Interferon-gamma release assay (IGRA) blood test that is claimed to be a superior alternative to the tuberculin skin test. QIAGEN noted that the fourth-generation QuantiFERON-TB ...
The QuantiFERON SARS-CoV-2 assay detects CD4+ and CD8+ T-cell responses, which enables a more comprehensive assessment of immunity generated by COVID-19 vaccines, including clinically vulnerable ...
QuantiFERON-TB Gold Plus (QFT-Plus) is widely recommended by leading health organizations, including the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention ...
The QuantiFERON SARS-CoV-2 assay is based on QIAGEN’s QuantiFERON interferon gamma release technology that is globally recognized as an easy-to-use T-cell assay which utilizes whole blood.
QIAGEN, a leading provider of innovative diagnostic solutions, plays a pivotal role in these efforts through its groundbreaking product, the QuantiFERON-TB Gold Plus test (QFT-Plus).
Tunisian Society of Nephrology first professional body in the field to publish nationwide guidanceAssociation of specialists recommends national immune response monitoring for cytomegalovirus (CMV) ...
QIAGEN Files Patent Complaint Against BioMérieux To Protect QuantiFERON Technology March 03, 2025 — 01:16 am EST Written by RTTNews.com for RTTNews -> ...